Table 1.
Sample list.
| State | Concentration | Medium | Name | Injection Volume (µL) |
|
|---|---|---|---|---|---|
| API (Lot #ALICEP-001-36C) |
lyophilized | 6 mg/mL | Water, formulation |
API1-w API1-f |
30 |
| API (Lot #MC-002-91D) |
lyophilized | 6 mg/mL | Water formulation |
API2-w API2-f |
30 |
| Finished dosage form (FDF) (Lot #33124-46) |
solution | 6 mg/mL | Formulation | FDF | 30 |
| Victoza (Lot #HS65J01) (Lot #KS6AH74) |
solution | 6 mg/mL | Formulation | Victoza1 Victoza2 |
30 |
| Saxenda (Lot #JP54138) |
solution | 6 mg/mL | Formulation | Saxenda | 30 |
| Stressed API (Lot #AF-001-95L) |
solution | 3 mg/mL | Formulation | APIaggr | 60 |
| Finished dosage form (FDF) (Lot #33387-18) |
solution | 6 mg/mL | Formulation | 30 | |
| Saxenda (Lot #JP54138) |
solution | 6 mg/mL | Formulation | 30 |
All chemicals were purchased from Merck KGaA, Darmstadt, Germany.